beta-lapachone has been researched along with Cryptococcosis in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medeiros, CS | 1 |
| Pontes-Filho, NT | 1 |
| Camara, CA | 1 |
| Lima-Filho, JV | 1 |
| Oliveira, PC | 1 |
| Lemos, SA | 1 |
| Leal, AF | 1 |
| Brandão, JO | 1 |
| Neves, RP | 1 |
1 other study available for beta-lapachone and Cryptococcosis
| Article | Year |
|---|---|
Antifungal activity of the naphthoquinone beta-lapachone against disseminated infection with Cryptococcus neoformans var. neoformans in dexamethasone-immunosuppressed Swiss mice.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dexamethasone; Immunocompromise | 2010 |